Longmen Capital
Overview
Longmen Capital is a venture capital firm specializing in the healthcare industry, focusing on innovative medicine research and early-stage investments. The team members have medical or biological backgrounds and many years of industry experience. Since its establishment in 2017, Longmen Capital has invested in more than 40 pharmaceutical innovation companies, with a fund management scale of over 2 billion yuan. Longmen Capital adheres to the principle of independent research and value discovery and aims to promote the industrialization of scientific and technological achievements with capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Moore Thread | Nov 2021 | Series A | - |
| Biren Technology | Jun 2020 | Series A | - |
| Chance Pharmaceuticals | Aug 2017 | Series D | Co-investor |
| SiBio | Oct 2017 | Series B | Co-investor |
| Siwei Biotechnology | Aug 2019 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Longmen Capital based?
Longmen Capital is headquartered in Zhuhai, Guangdong, China.
When was Longmen Capital founded?
Longmen Capital was founded in 2017.
How many portfolio companies does Longmen Capital have?
Longmen Capital has 20 portfolio companies in Caplight's dataset.
What are some companies in Longmen Capital's portfolio?
Portfolio companies visible on Caplight include Moore Thread, Biren Technology, Chance Pharmaceuticals, SiBio, Siwei Biotechnology.
What was Longmen Capital's most recent investment shown here?
Longmen Capital's most recent investment in this portfolio sample was in Moore Thread in 2021.
What sectors does Longmen Capital focus on?
Longmen Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Enterprise Software, Media, Entertainment & Gaming, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Longmen Capital focus on?
Longmen Capital typically invests at the Early stage.
What is Longmen Capital's AUM?
Longmen Capital's assets under management are estimated between $250.0M and $500.0M.